WILLIAM G WIERDA to Waldenstrom Macroglobulinemia
This is a "connection" page, showing publications WILLIAM G WIERDA has written about Waldenstrom Macroglobulinemia.
Connection Strength
0.146
-
Long-term Follow-up of Patients with Relapsed or Refractory Non-Hodgkin Lymphoma Treated with Venetoclax in a Phase I, First-in-Human Study. Clin Cancer Res. 2021 09 01; 27(17):4690-4695.
Score: 0.146